Regarding this:
https://www.biospace.com/fda/fdas-prasad-vows-to-make-rare-disease-drugs-available-at-first-sign-of-promiseOn the surface this sounds like good news. But let’s not skip steps. The FDA saying they'll move faster if there's promise does not automatically mean IMU benefits.
They hinted at rare indications, but until we know what those are and see actual early data, this is just hopeful interpretation, not confirmation.
We should get excited when LC stops teasing and actually delivers specifics. Until then, it’s a nice headline, not a catalyst!!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $255.7K | 18.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 18692454 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4515891 | 5 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |